• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮屏障的短暂破坏会导致调节性T细胞的产生以及对实验性结肠炎的抗性。

A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.

作者信息

Boirivant Monica, Amendola Antonello, Butera Alessia, Sanchez Massimo, Xu Lili, Marinaro Mariarosaria, Kitani Atsushi, Di Giacinto Claudia, Strober Warren, Fuss Ivan J

机构信息

Immune-Mediated Diseases Section, Department of Infectious, Parasitic, and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Gastroenterology. 2008 Nov;135(5):1612-1623.e5. doi: 10.1053/j.gastro.2008.07.028. Epub 2008 Aug 5.

DOI:10.1053/j.gastro.2008.07.028
PMID:18765239
Abstract

BACKGROUND & AIMS: Previous studies have indicated that a defective epithelial barrier leads to inflammation of the underlying lamina propria. Nevertheless, it is likely that physiologic breaks in the barrier must occur for homeostatic regulatory T cells to develop. We determined the effect of agents that disrupt epithelial tight junctions (ethanol and AT1002, a Vibrio cholerae zonula occludens toxin hexapeptide) on regulatory T-cell induction and resistance to induction of colitis by trinitrobenzene sulfonic acid (TNBS).

METHODS

The effects of ethanol and AT1002 on colon immune function were evaluated by their capacity to induce direct phenotypic or functional changes in effector and regulatory cell populations and their indirect effect on the development of TNBS-induced colitis. The basis of regulatory cell development was evaluated with in vitro studies of isolated dendritic cell populations. The role of innate immunity was evaluated by in vivo gene silencing studies utilizing Toll-like receptor (TLR)-2-specific small interfering RNA (siRNA).

RESULTS

Both ethanol and AT1002 induced persistent latency-associated peptide-positive CD4(+) regulatory T cells that, as shown in adoptive transfer studies, render mice resistant to the induction of TNBS colitis. The development of these cells requires the presence of an intact microflora and the activity of CD11c(+) dendritic cells. Their induction is also influenced by innate immune factors operating through TLR-2, because attenuation of TLR-2 signaling by in vivo TLR-2 siRNA administration prevents their development.

CONCLUSIONS

A mild and/or transient breach in epithelial barrier function leads to dominant regulatory T-cell responses that protect the mucosa from inflammation.

摘要

背景与目的

既往研究表明,上皮屏障缺陷会导致其下方固有层发生炎症。然而,为使稳态调节性T细胞得以发育,屏障中的生理性破损可能是必需的。我们测定了破坏上皮紧密连接的试剂(乙醇和AT1002,一种霍乱弧菌小带闭合毒素六肽)对调节性T细胞诱导以及对三硝基苯磺酸(TNBS)诱导的结肠炎的诱导抗性的影响。

方法

通过乙醇和AT1002诱导效应细胞和调节细胞群体直接表型或功能变化的能力及其对TNBS诱导的结肠炎发展的间接影响,来评估它们对结肠免疫功能的作用。通过对分离的树突状细胞群体进行体外研究,评估调节性细胞发育的基础。利用Toll样受体(TLR)-2特异性小干扰RNA(siRNA)进行体内基因沉默研究,评估天然免疫的作用。

结果

乙醇和AT1002均诱导出持续的潜伏期相关肽阳性CD4(+)调节性T细胞,如过继转移研究所显示的,这些细胞使小鼠对TNBS结肠炎的诱导具有抗性。这些细胞的发育需要完整的微生物群的存在以及CD11c(+)树突状细胞的活性。它们的诱导也受通过TLR-2发挥作用的天然免疫因子的影响,因为体内给予TLR-2 siRNA减弱TLR-2信号会阻止它们的发育。

结论

上皮屏障功能的轻度和/或短暂破损会导致占主导地位的调节性T细胞反应,从而保护黏膜免受炎症侵袭。

相似文献

1
A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.上皮屏障的短暂破坏会导致调节性T细胞的产生以及对实验性结肠炎的抗性。
Gastroenterology. 2008 Nov;135(5):1612-1623.e5. doi: 10.1053/j.gastro.2008.07.028. Epub 2008 Aug 5.
2
Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.TNBS诱导的结肠炎中,CD80阻断对结肠上皮细胞反应的调节及炎症的改善作用
Clin Immunol. 2009 Dec;133(3):411-21. doi: 10.1016/j.clim.2009.09.001. Epub 2009 Oct 7.
3
VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.血管活性肠肽(VIP)平衡由Toll样受体2(TLR2)和Toll样受体4(TLR4)的特异性刺激所诱导的先天性和适应性免疫反应。
Peptides. 2008 Jun;29(6):948-56. doi: 10.1016/j.peptides.2008.01.019. Epub 2008 Feb 7.
4
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.重定向具有预定特异性的调节性T细胞用于治疗小鼠实验性结肠炎。
Gastroenterology. 2008 Jun;134(7):2014-24. doi: 10.1053/j.gastro.2008.02.060. Epub 2008 Mar 4.
5
RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.RANK-RANKL信号通路在慢性结肠炎中CD4+CD25+调节性T细胞的功能中起关键作用。
J Immunol. 2009 May 15;182(10):6079-87. doi: 10.4049/jimmunol.0711823.
6
Regulation of gut inflammation and th17 cell response by interleukin-21.白细胞介素-21对肠道炎症和Th17细胞反应的调节
Gastroenterology. 2008 Apr;134(4):1038-48. doi: 10.1053/j.gastro.2008.01.041. Epub 2008 Jan 17.
7
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.半抗原诱导的小鼠炎症性肠病模型:黏膜免疫反应及耐受性保护
J Immunol. 1996 Sep 1;157(5):2174-85.
8
Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.Smad7控制致结肠炎T细胞对调节性T细胞介导抑制的抗性。
Gastroenterology. 2009 Apr;136(4):1308-16, e1-3. doi: 10.1053/j.gastro.2008.12.053. Epub 2008 Dec 27.
9
TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.TWEAK/Fn14信号通路:通过TWEAK/肠上皮细胞轴在小鼠肠道损伤中发挥非冗余作用。
Gastroenterology. 2009 Mar;136(3):912-23. doi: 10.1053/j.gastro.2008.11.017. Epub 2008 Nov 8.
10
Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.用血管活性肠肽产生的调节性树突状细胞对实验性结肠炎进行治疗
Gastroenterology. 2006 Dec;131(6):1799-811. doi: 10.1053/j.gastro.2006.10.023. Epub 2006 Oct 15.

引用本文的文献

1
Sodium orthovanadate protects against ulcerative colitis and associated liver damage in mice: insights into modulations of Nrf2/Keap1 and NF-κB pathways.原钒酸钠可保护小鼠免受溃疡性结肠炎及相关肝损伤:对Nrf2/Keap1和NF-κB信号通路调节的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1557-1574. doi: 10.1007/s00210-024-03335-w. Epub 2024 Aug 9.
2
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?黏膜愈合的机制:不使用免疫抑制剂治疗炎症性肠病?
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):493-507. doi: 10.1038/s41575-022-00604-y. Epub 2022 Apr 19.
3
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
模式识别受体信号和细胞因子网络在微生物防御和肠道屏障调节中的作用:对炎症性肠病的影响。
Gastroenterology. 2022 May;162(6):1602-1616.e6. doi: 10.1053/j.gastro.2021.12.288. Epub 2022 Feb 9.
4
Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.肠道微生物代谢物介导的炎症性肠病发病机制中的肠道屏障调节。
Nutrients. 2021 Nov 26;13(12):4259. doi: 10.3390/nu13124259.
5
Overexpression of Vitamin D Receptor in Intestinal Epithelia Protects Against Colitis via Upregulating Tight Junction Protein Claudin 15.维生素 D 受体在肠上皮细胞中的过表达通过上调紧密连接蛋白 Claudin 15 来保护免受结肠炎的侵害。
J Crohns Colitis. 2021 Oct 7;15(10):1720-1736. doi: 10.1093/ecco-jcc/jjab044.
6
CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.结直肠固有层中的 CD3+CD4+LAP+Foxp3-调节性细胞限制溃疡性结肠炎的疾病进展。
Front Immunol. 2018 Oct 30;9:2511. doi: 10.3389/fimmu.2018.02511. eCollection 2018.
7
Nod2 Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+ LAP+ Regulatory Cells.Nod2 缺陷型小鼠的微生物组存在有利于黏膜 CD4+LAP+调节性细胞扩增的变异。
Sci Rep. 2018 Sep 24;8(1):14241. doi: 10.1038/s41598-018-32583-z.
8
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.鸟苷酸环化酶C - 环磷酸鸟苷信号轴对抗肠道上皮损伤和肿瘤形成。
Front Oncol. 2018 Aug 6;8:299. doi: 10.3389/fonc.2018.00299. eCollection 2018.
9
Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.短链脂肪酸受体在肠道生理学和病理生理学中的作用。
Compr Physiol. 2018 Jun 18;8(3):1091-1115. doi: 10.1002/cphy.c170050.
10
The Microbiome Activates CD4 T-cell-mediated Immunity to Compensate for Increased Intestinal Permeability.微生物群激活CD4 T细胞介导的免疫以补偿肠道通透性增加。
Cell Mol Gastroenterol Hepatol. 2017 Jun 10;4(2):285-297. doi: 10.1016/j.jcmgh.2017.06.001. eCollection 2017 Sep.